Published • loading... • Updated
Florida Attorney General Targets Insulin, Diabetes-Related Drug Prices in New Lawsuit
The state alleges the companies inflated insulin list prices and used rebates to shift costs onto patients and independent pharmacists.
Summary by FOX13news
2 Articles
2 Articles
Uthmeier takes aim at insulin pricing in new Florida lawsuit
TAMPA, Fla. — Florida Attorney General James Uthmeier announced a lawsuit Tuesday against major insulin manufacturers and pharmacy benefit managers, accusing the companies of price fixing, anti-competitive behavior and deceptive trade practices. The lawsuit targets insulin manufacturers Eli Lilly, Novo Nordisk and Sanofi, along with pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx. It… The post Uthmeier takes aim at insulin pr…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
